Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Dermatology/Plastic Surgery
Clinical Trials: Rosacea
A listing of clinical trials currently looking for volunteers to enroll in Rosacea studies. Click on the closest city to find more detailed information on a research study in your area.
Phoenix : Elite Clinical Studies, LLC
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Hot Springs : Burke Pharmaceutical Research Updated
Phase 3 Papulopustular Rosacea Study
Hot Springs : Novartis Investigative Site
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
Long Beach : Alliance Research Center
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Newport Beach : Silverberg Surgical and Medical Group
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Oceanside : Dermatology Specialists, Inc Updated
Phase 3 Papulopustular Rosacea Study
Riverside : Integrated Research Group, Inc Updated
Phase 3 Papulopustular Rosacea Study
San Diego : Therapeutics Clinical Research Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
View More »
San Diego : Therapeutics Clinical Research Updated
Phase 3 Papulopustular Rosacea Study
Santa Monica : ATS Clinical Research Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Santa Rosa : Redwood Dermatology Research Updated
Phase 3 Papulopustular Rosacea Study
Stanford : Department of Dermatology - Stanford School of Medicine
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Denver : Horizons Clinical Research Center, LLC
Now enrolling for a clinical research study for the treatment of Rosacea.
View More »
Denver : Horizon Clinical Research Center
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Coral Gables : Dadeland Dermatology Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Jacksonville : North Florida Dermatology Associates
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Jacksonville : North Florida Dermatology Associates
Phase 3 Papulopustular Rosacea Study
Miami : FXM Research Corp.
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Miami : International Dermatology Research, Inc.
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
View More »
Miramar : FXM Research Miramar
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Ormond Beach : Leavitt Medical Associates of Florida dba Ameriderm Research Updated
Phase 3 Papulopustular Rosacea Study
Arlington Heights : Altman Dermatology Associates
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Evansville : Hudson Dermatology Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Plainfield : The Indiana Clinical Trials Center, PC
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Plainfield : The Indiana Clinical Trials Center Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Corbin : Melissa L. F. Knuckles M.D., P.S.C. Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Louisville : Dermatology Specialists Research Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Richmond : Melissa L. F. Knuckles M.D., P.S.C. Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Hunt Valley : The Maryland Laser, Skin, and Vein Institute, LLC Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Boston : CURTIS - Massachussetts General Hospital
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Ann Arbor : University of Michigan Department of Dermatology
Atralin Gel for the Treatment of Rosacea
Clinton Township : Michigan Center for Research Corp Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Warren : Grekin Skin Institute Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Henderson : Las Vegas Skin & Cancer Clinic
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Paramus : Novartis Investigative Site
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
West Windsor : Psoriasis Treatment Center of NJ Updated
Phase 3 Papulopustular Rosacea Study
Brooklyn : Hilary Baldwin Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
New York : Columbia University Medical Center
Open Label Pilot Study of Apremilast in Treatment of Rosacea
Rochester : The Center for Dermatology at Linden Oaks Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Rochester : Skin Search of Rochester, Inc Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Stony Brook : DermResearch Center of New York, Inc Updated
Phase 3 Papulopustular Rosacea Study
Charlotte : PMG Research of Charlotte
Do You Have Moderate to Severe Rosacea (redness on checks, nose, chin or forehead) and bumps?
Hickory : PMG Research of Hickory
Do You Have Moderate to Severe Rosacea?
Raleigh : PMG Research of Raleigh
Rosacea: Volunteers Needed for Rosacea Research Study
Wilmington : PMG Research of Wilmington
Do You Have Moderate to Severe Rosacea?
Winston Salem : PMG Research of Wilmington
Do You Suffer From Facial Redness?
View More »
Hickory : PMG Research of Hickory, LLC
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
High Point : Call for Information
A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155 AM1)
High Point : Dermatology Consulting Services
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
High Point : Updated
Phase 3 Papulopustular Rosacea Study
Raleigh : PMG Research of Raleigh, LLC Updated
Phase 3 Papulopustular Rosacea Study
Wilmington : New Hanover Medical Research PMG
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
South Euclid : Haber Dermatology and Cosmetic Surgery, Inc.
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Warren : Brodell Medical, Inc. Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Portland : Center for Dermatology and Laser Surgery Updated
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo After 12 Weeks of Oracea® and MetroGel® 1%
Portland : Oregon Medical Research Center, PC Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Portland : Oregon Dermatology and Research Center Updated
Phase 3 Papulopustular Rosacea Study
Portland : Novartis Investigative Site
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
Fort Washington : Philadelphia Institute of Dermatology Updated
Phase 3 Papulopustular Rosacea Study
Hazelton : Dermatology Centers of NE PA
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Philadelphia : Paddington Research Updated
Phase 3 Papulopustular Rosacea Study
Yardley : Yardley Dermatology Associates Updated
Phase 3 Papulopustular Rosacea Study
Mount Pleasant : PMG Research of Charleston
Do You Have Moderate to Severe Rosacea (redness on checks, nose, chin or forehead) and bumps?
View More »
Simpsonville : Marshall Shuler, MD
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Bristol : PMG Research of Bristol
Do You Have Moderate to Severe Rosacea (redness on checks, nose, chin or forehead) and bumps?
Bristol : PMG Research of Bristol
Do You Have Moderate to Severe Rosacea?
View More »
Kingsport : Dermatology Associates of Kingsport, PC
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Knoxville : Dermatology Associates of Knoxville
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Nashville : Tennessee Clinical Research
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
San Antonio : Progressive Clinical Research Updated New
Is your skin red around your forehead, cheeks, chin and nose? Do you also get red bumps similar to acne on your face?
View More »
Arlington : Arlington Research Center, Inc Updated
Phase 3 Papulopustular Rosacea Study
Austin : Derm Research Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Austin : DermResearch, Inc.
Phase 3 Papulopustular Rosacea Study
Austin : Novartis Investigative Site
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
College Station : J & S Studies, Inc. Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Dallas : Modern Research Associates
Phase 3 Papulopustular Rosacea Study
Houston : Suzanne Bruce and Associates, PA Updated
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
San Antonio : Dermatology San Antonio
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
San Antonio : Updated
Phase 3 Papulopustular Rosacea Study
Webster : Center for Clinical Studies
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Webster : Center for Clinical Studies Updated
Phase 3 Papulopustular Rosacea Study
West Jordan : South Valley Dermatology
A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea
Spokane : Novartis Investigative Site
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
Natanya : Lev Yasmin Clinic
Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
